68Ga-FAPI PET/CT在转移性小叶乳腺癌检测中的作用
这项前瞻性小样本先导研究纳入7例非18F-FDG亲和的转移性浸润性小叶乳腺癌女性患者,比较68Ga-FAPI PET/CT与同期全诊断CT的检出情况;在30个受肿瘤累及的器官和结构中,FAPI PET/CT发现的病灶数显著高于单独CT(P=0.022),尤其在浸润性软组织和浆膜部位;作者认为68Ga-FAPI PET/CT在小叶乳腺癌中可能发挥作用,尚需后续试验证实。
要点
- 7例非18F-FDG亲和的转移性浸润性小叶乳腺癌患者接受68Ga-FAPI PET/CT检查。
- 30个受肿瘤累及的器官和结构中,FAPI PET/CT检出数显著高于单独CT(P=0.022)。
- 差异尤其在浸润性软组织和浆膜部位;作者认为该结果尚需后续试验证实。
核心结论
- 作者认为,这项小型先导试验提示68Ga-FAPI PET/CT在浸润性小叶乳腺癌中可能发挥作用,尚需后续试验证实。
研究设计与样本
- 前瞻性研究,纳入转移性浸润性小叶乳腺癌且浸润软组织、病灶非18F-FDG亲和的女性患者7例(年龄57±10岁)。
- 患者接受68Ga-FAPI PET/CT评估,并与同期完成的全诊断CT进行相关性分析。
主要发现
- 共发现30个受肿瘤累及的器官和结构,FAPI PET/CT观察到的病灶数显著高于单独CT(P=0.022)。
- FAPI PET/CT与单独CT检出数的差异尤其在浸润性软组织和浆膜部位。
局限性
- 作者称本研究为小型先导试验,结果尚需后续试验证实。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Invasive lobular breast cancer (ILC) may be hard to detect using conventional imaging modalities and usually shows less avidity to 18 F-FDG PET/CT. 68 Ga-fibroblast activation protein inhibitor (FAPI) PET/CT has shown promising results in detecting non- 18 F-FDG-avid cancers. We aimed to assess the feasibility of detecting metastatic disease in patients with non- 18 F-FDG-avid ILC. METHODS: This prospective study included patients with metastatic ILC, infiltrative to soft tissues, which was not 18 F-FDG avid. The patients underwent 68 Ga-FAPI PET/CT for evaluation, which was correlated with the fully diagnostic CT performed at the same time. RESULTS: Seven women (aged 57 ± 10 years) were included. Among the 30 organs and structures found to be involved by tumor, the number of findings observed by FAPI PET/CT was significantly higher than that observed by CT alone ( P = 0.022), especially in infiltrative soft tissue and serosal locations. CONCLUSIONS: This small pilot trial suggests a role for 68 Ga-FAPI PET/CT in ILC, which needs to be confirmed by subsequent trials.
引用
- Eshet Y, Tau N, Apter S, et al. The Role of 68 Ga-FAPI PET/CT in Detection of Metastatic Lobular Breast Cancer. Clin Nucl Med. 2023. PMID: 36638243. doi:10.1097/RLU.0000000000004540
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。